Biogen Inc. (BIIB)
NASDAQ: BIIB · IEX Real-Time Price · USD
230.60
+0.03 (0.01%)
May 20, 2024, 11:23 AM EDT - Market open
Biogen Stock Forecast
Stock Price Forecast
The 23 analysts with 12-month price forecasts for Biogen stock have an average target of 288.83, with a low estimate of 200 and a high estimate of 373. The average target predicts an increase of 25.25% from the current stock price of 230.60.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Biogen stock from 23 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 9 | 9 | 9 | 9 | 7 |
| Buy | 12 | 12 | 10 | 10 | 9 | 9 |
| Hold | 4 | 5 | 6 | 6 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 26 | 26 | 25 | 25 | 25 | 23 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $340 | Strong Buy | Maintains | $340 | +47.44% | May 16, 2024 |
| HSBC | HSBC | Strong Buy Maintains $339 → $342 | Strong Buy | Maintains | $339 → $342 | +48.31% | May 3, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $270 | Buy | Maintains | $270 | +17.09% | Apr 29, 2024 |
| Barclays | Barclays | Hold Maintains $215 → $200 | Hold | Maintains | $215 → $200 | -13.27% | Apr 25, 2024 |
| Wedbush | Wedbush | Hold Maintains $213 → $215 | Hold | Maintains | $213 → $215 | -6.76% | Apr 25, 2024 |
Financial Forecast
Revenue This Year
9.64B
from 9.84B
Decreased by -1.95%
Revenue Next Year
9.78B
from 9.64B
Increased by 1.36%
EPS This Year
15.76
from 7.97
Increased by 97.75%
EPS Next Year
17.98
from 15.76
Increased by 14.09%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 10.2B | 12.0B | 13.1B | 12.9B | 14.1B |
| Avg | 9.6B | 9.8B | 10.3B | 10.5B | 10.9B |
| Low | 8.8B | 8.3B | 8.6B | 8.7B | 9.0B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 4.2% | 24.7% | 33.8% | 24.9% | 34.2% |
| Avg | -1.9% | 1.4% | 5.4% | 2.0% | 3.7% |
| Low | -10.5% | -14.4% | -12.5% | -15.4% | -14.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 16.89 | 22.46 | 28.83 | 27.46 | 30.29 |
| Avg | 15.76 | 17.98 | 20.30 | 21.24 | 22.93 |
| Low | 14.53 | 12.08 | 12.36 | 14.81 | 15.84 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 111.9% | 42.5% | 60.3% | 35.3% | 42.6% |
| Avg | 97.8% | 14.1% | 12.9% | 4.6% | 8.0% |
| Low | 82.4% | -23.3% | -31.3% | -27.1% | -25.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.